These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16937477)

  • 21. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
    El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
    Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of iron load on fibrogenesis in chronic hepatitis C.
    Casaril M; Stanzial AM; Tognella P; Pantalena M; Capra F; Colombari R; Corrocher R
    Hepatogastroenterology; 2000; 47(31):220-5. PubMed ID: 10690612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum iron indices as a measure of iron deposits in chronic hepatitis C.
    Fabris C; Toniutto P; Scott CA; Falleti E; Avellini C; Del Forno M; Mattiuzzo M; Branca B; Pirisi M
    Clin Chim Acta; 2001 Feb; 304(1-2):49-55. PubMed ID: 11165198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy.
    Liang CC; Liu CH; Chung CS; Lin CK; Su TH; Yang HC; Liu CJ; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2015 May; 211(9):1429-36. PubMed ID: 25387585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan.
    Kage M; Fujisawa T; Shiraki K; Tanaka T; Fujisawa T; Kimura A; Shimamatsu K; Nakashima E; Kojiro M; Koike M; Tazawa Y; Abukawa D; Okaniwa M; Takita H; Matsui A; Hayashi T; Etou T; Terasawa S; Sugiyama K; Tajiri H; Yoden A; Kajiwara Y; Sata M; Uchimura Y
    Hepatology; 1997 Sep; 26(3):771-5. PubMed ID: 9303511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.
    Lange CM; Kutalik Z; Morikawa K; Bibert S; Cerny A; Dollenmaier G; Dufour JF; Gerlach TJ; Heim MH; Malinverni R; Müllhaupt B; Negro F; Moradpour D; Bochud PY;
    Hepatology; 2012 Apr; 55(4):1038-47. PubMed ID: 22095909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
    Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
    Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection.
    Jin YJ; Shim JH; Kim GA; Yu E; Kim KM; Lim YS; Lee HC
    BMJ Open; 2014 Nov; 4(11):e006255. PubMed ID: 25431223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N; Sugimoto R; Takeo M; Urawa N; Mifuji R; Tanaka H; Kobayashi Y; Iwasa M; Watanabe S; Adachi Y; Kaito M
    Mol Med; 2007; 13(1-2):97-104. PubMed ID: 17515961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic hepatitis C is mild in menstruating women.
    Sartori M; Andorno S; Rigamonti C; Grossini E; Nicosia G; Boldorini R
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1411-7. PubMed ID: 11197052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum vitamin D₃ does not correlate with liver fibrosis in chronic hepatitis C.
    Ren Y; Liu M; Zhao J; Ren F; Chen Y; Li JF; Zhang JY; Qu F; Zhang JL; Duan ZP; Zheng SJ
    World J Gastroenterol; 2015 Oct; 21(39):11152-9. PubMed ID: 26494969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
    Alexander J; Tung BY; Croghan A; Kowdley KV
    Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus.
    Sebastiani G; Tempesta D; Alberti A
    J Viral Hepat; 2012 Feb; 19(2):e170-6. PubMed ID: 22239515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.